ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Knight Therapeutics Inc

Knight Therapeutics Inc (GUD)

5,37
0,03
(0,56%)
Fermé 05 Janvier 10:12PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
5,37
Prix Achat
5,37
Prix Vente
5,40
Volume échangé
22 259
5,35 Fourchette du Jour 5,41
5,09 Plage de 52 semaines 6,23
Cap du marché
Clôture Veille
5,34
Ouverture
5,35
Dernière Transaction
56
@
5.37
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
121 195
Actions en circulation
101 170 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-32,33
Bénéfice par action (BPA)
-0,17
Chiffre d'affairess
331,1M
Bénéfice net
-16,84M

À propos de Knight Therapeutics Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Montreal, Quebec, Can
Fondé
-
Knight Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la Toronto Stock Exchange avec le ticker GUD. Le dernier cours de clôture d'Knight Therapeutics était de $5,34. Au cours de la dernière année, les actions de Knight Therapeutics ont été négociées dans une fourchette de prix de $ 5,09 à $ 6,23.

Knight Therapeutics compte actuellement 101 170 000 actions en circulation. La capitalisation boursière d'Knight Therapeutics est de $540,25 million. Knight Therapeutics a un ratio cours/bénéfice (ratio PE) de -32.33.

GUD Dernières nouvelles

Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (viloxazine) in Canada

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Knight's New Drug...

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Mexico

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate...

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has...

Knight Therapeutics Reports Third Quarter 2024

MONTREAL, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported...

Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call

MONTREAL, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its third quarter 2024...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico

MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate...

Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies

MONTREAL, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 397 on the 2024 Report on Business magazine’s...

Knight Therapeutics Reports Second Quarter 2024

MONTREAL, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan- American (ex-US) specialty pharmaceutical company, today reported...

Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call

MONTREAL, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2024...

Knight Announces Normal Course Issuer Bid

MONTREAL, July 11, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company "),  a leading pan-American (ex-US) specialty pharmaceutical company, announced today...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.122.285714285715.255.415.25599665.32475498CS
40.030.5617977528095.345.415.11667865.24228569CS
12-0.41-7.093425605545.785.825.091211955.29622638CS
26-0.35-6.118881118885.726.235.09877185.47940628CS
520.234.474708171215.146.235.09782325.53602788CS
1560.061.129943502825.316.234.281097595.2857133CS
260-2.28-29.80392156867.658.124.282039945.69048328CS

GUD - Frequently Asked Questions (FAQ)

What is the current Knight Therapeutics share price?
The current share price of Knight Therapeutics is $ 5,37
How many Knight Therapeutics shares are in issue?
Knight Therapeutics has 101 170 000 shares in issue
What is the market cap of Knight Therapeutics?
The market capitalisation of Knight Therapeutics is CAD 540,25M
What is the 1 year trading range for Knight Therapeutics share price?
Knight Therapeutics has traded in the range of $ 5,09 to $ 6,23 during the past year
What is the PE ratio of Knight Therapeutics?
The price to earnings ratio of Knight Therapeutics is -32,33
What is the cash to sales ratio of Knight Therapeutics?
The cash to sales ratio of Knight Therapeutics is 1,64
What is the reporting currency for Knight Therapeutics?
Knight Therapeutics reports financial results in CAD
What is the latest annual turnover for Knight Therapeutics?
The latest annual turnover of Knight Therapeutics is CAD 331,1M
What is the latest annual profit for Knight Therapeutics?
The latest annual profit of Knight Therapeutics is CAD -16,84M
What is the registered address of Knight Therapeutics?
The registered address for Knight Therapeutics is 3400 DE MAISONNEUVE W, SUITE 1055, MONTREAL, QUEBEC, H3Z 3B8
What is the Knight Therapeutics website address?
The website address for Knight Therapeutics is www.gudknight.com
Which industry sector does Knight Therapeutics operate in?
Knight Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DIAMStar Diamond Corporation
$ 0,025
(25,00%)
17,1k
CSCICOSCIENS Biopharma Inc
$ 4,80
(22,14%)
11,2k
DII.BDorel Industries Inc
$ 4,88
(20,49%)
33,64k
ORVOrvana Minerals Corp
$ 0,28
(16,67%)
104,72k
YRBYorbeau Resources Inc
$ 0,04
(14,29%)
671k
FLNTFlint Corporation
$ 0,025
(-16,67%)
17k
RTGRTG Mining Inc
$ 0,03
(-14,29%)
544,49k
TWMTidewater Midstream and Infrastructure Ltd
$ 0,15
(-11,76%)
541,46k
EXROExro Technologies Inc
$ 0,13
(-10,34%)
676,19k
ASTLAlgoma Steel Group Inc
$ 12,92
(-7,58%)
196,97k
TDToronto Dominion Bank
$ 77,79
(1,69%)
17,95M
VRNVeren Inc
$ 7,48
(-1,32%)
6,26M
CNQCanadian Natural Resources Ltd
$ 45,61
(0,95%)
4,64M
ACAir Canada
$ 22,31
(-0,13%)
3,84M
BBBlackBerry Limited
$ 5,34
(-3,09%)
3,79M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock